(i) If a manufacturer believes there are multiple events causing severe supply chain disruptions during the same applicable period for the same generic Part D rebatable drug or biosimilar and submits multiple rebate reduction requests for the same drug or biosimilar, CMS will grant no more than 1 rebate reduction under paragraph (b)(1) or (2) of this section for that product for the applicable period
However, we emphasize that DCAPS drugs that are also covered under Part B for non-preventive indications (that is, are also used for diagnosis or treatment) would be subject to ASP reporting requirements
When determining whether to reopen an ACO's payment determination, we anticipate considering a combination of factors including: The dollar value of improper payments and the number of claims or line items impacted (if applicable)
Now, along with the exponential growth in recreational use by children and young adults, there is increasing evidence of harm
If you suspect your child chewed or swallowed a piece of nicotine gum, call IPC immediately at 1-800-222-1222 for advice specific to your situation
